Elsevier Launches New Journal: Multiple Sclerosis and Related Disorders

LONDON, June 8, 2011 -

- Special Advance Issue to be Freely Available in October 2011

Elsevier, a world-leading provider of scientific, technical and medical
information products and solutions, is pleased to announce the launch of a
new journal, Multiple Sclerosis and Related Disorders (
www.MSARD-journal.com) with its first issue publication in January
2012. Published quarterly, complimentary print copies of the advance issue of
the journal will be available at the 5th Joint Triennial Congress of the
European and American Committees for Treatment and Research in Multiple
Sclerosis, to take place in in Amsterdam, the Netherlands, 19-22 October
2011.

Multiple Sclerosis is an area of ever expanding research and escalating
publications. Multiple Sclerosis and Related Disorders is a wide ranging
international journal supported by key researchers from all neuroscience
domains that focus on Multiple Sclerosis and associated disease of the
nervous system. The primary aim of this new journal is the rapid publication
of high quality original research in the field. Important secondary aims will
be timely updates and editorials on important scientific and clinical care
advances, controversies in the field, and invited opinion articles from
current thought leaders on topical issues.

The journal Multiple Sclerosis and Related Disorders (MSARD) will be
mostly web based with the ultimate aim of web and e-reader only versions,
save for institutional subscribers that may wish to have a shelf copy. MSARD
will have a journal club, an associated Wiki and Twitter account to create an
MS community and include an RSS feed. A special section will be created to
provide timely information on key discoveries written for a lay audience- a
resource accessible by the public and suited for physicians who wish to
provide patients with information.

The Journal's Chief Editors are: Professor Gavin Giovannoni PhD, FCP,
FRCP, FRCPath. Lead, Centre for Neuroscience and Trauma, Barts and The London
School of Medicine and Dentistry; Professor Christopher H. Hawkes MD FRCP.
Honorary Professor of Neurology, Centre for Neuroscience and Trauma, Barts
and The London School of Medicine and Dentistry; Professor Fred D. Lublin,
MD, Saunders Family Professor of Neurology, Corinne Goldsmith Dickinson
Center for Multiple Sclerosis, Mount Sinai School of Medicine, New York; and,
Dr Brenda Banwell MD. Department of Pediatrics, Division of Neurology, The
Hospital for Sick Children, University of Toronto.

The team of chief editors is supported by leading section editors who
will commission and appraise original and review articles concerning:
clinical neurology, neuroimaging, neuropathology, neuroepidemiology,
therapeutics, genetics / transcriptomics, experimental models,
neuroimmunology, biomarkers, neuropsychology, neurorehabilitation,
measurement scales, teaching, neuroethics and lay communication.

The first, advance issue of the Multiple Sclerosis and Related
Disorders will be freely available online on SciVerse ScienceDirect and
Elsevier Health Advance during the 4th quarter of 2011.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com/) and Cell
(www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com/), SciVerse Scopus
(www.scopus.com/), Reaxys (www.reaxys.com/), MD Consult
(www.mdconsult.com/) and Nursing Consult (
www.nursingconsult.com/), which enhance the productivity of science
and health professionals, and the SciVal suite (www.scival.com/) and
MEDai's Pinpoint Review (www.medai.com/), which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com/), employs 7,000 people worldwide. The company is
part of Reed Elsevier Group PLC (www.reedelsevier.com/), a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Exchange).

    Media contact
    Khatagova Ruslana
    +44(0)20-7424-4302
    r.khatgova@elsevier.com

.